Multiple Myeloma: Increasing Evidence for a Multistep Transformation Process-Reference-Cited by-同舟云学术

Multiple Myeloma: Increasing Evidence for a Multistep Transformation Process

Published:1998-01-01 Issue:1 Volume:91 Page:3-21
ISSN:1528-0020
Container-title:Blood
language:en
Short-container-title:

Author:

Hallek Michael¹,Leif Bergsagel P.¹,Anderson Kenneth C.¹

Affiliation:

1. From Medizinische Klinik, Klinikum Innenstadt, and Genzentrum, Universität München, München, Germany; Cornell University Medical College, New York, NY; and Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/91/1/3/1415200/3.pdf

Reference316 articles.

1. Myeloma Ig heavy chain V region sequences reveal prior antigenic selection and marked somatic mutation but no intraclonal diversity.;Vescio;J Immunol,1995

2. Interleukin-6 in human multiple myeloma.;Klein;Blood,1995

3. Evidence that multiple myeloma Ig heavy chain VDJ genes contain somatic mutations but show no intraclonal variation.;Bakkus;Blood,1992

4. Non-random chromosomal aberrations associated with multiple myeloma.;Lewis;Hematol Oncol,1984

5. The clinical significance of cytogenetic studies in 100 patients with multiple myeloma, plasma cell leukemia, or amyloidosis.;Dewald;Blood,1985

Cited by 523 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Selenoprotein W engages in overactive osteoclast differentiation in multiple myeloma;Molecular Biology Reports;2024-04-29

2. p38 Molecular Targeting for Next-Generation Multiple Myeloma Therapy;Cancers;2024-01-06

3. Utilizing MobileNetV2 for Enhanced Blood Cancer Detection;2023 International Conference on Artificial Intelligence for Innovations in Healthcare Industries (ICAIIHI);2023-12-29

4. Plasma cell myeloma with double M bands on Serum protein electrophoresis: A diagnostic conundrum?;Journal of Cancer Research and Therapeutics;2023-12-15

5. Evidence-based mechanisms of synergy with IMiD agent-based combinations in multiple myeloma;Critical Reviews in Oncology/Hematology;2023-08